154 related articles for article (PubMed ID: 8245898)
1. Varicella-zoster virus infection in immunocompromised patients.
Masaoka T; Hiraoka A; Teshima H; Tominaga N
J Med Virol; 1993; Suppl 1():82-4. PubMed ID: 8245898
[TBL] [Abstract][Full Text] [Related]
2. Early relapses of varicella-zoster virus infection in immunocompromised children treated with acyclovir.
Mészner Z; Gyarmati E; Nyerges G; Simon M; Koller M
Acta Paediatr Hung; 1990; 30(2):263-70. PubMed ID: 2248805
[TBL] [Abstract][Full Text] [Related]
3. Current management of varicella zoster virus infections.
Balfour HH
J Med Virol; 1993; Suppl 1():74-81. PubMed ID: 8245897
[TBL] [Abstract][Full Text] [Related]
4. Varicella-zoster virus infections in the immunocompromised host. Natural history and treatment.
Balfour HH
Scand J Infect Dis Suppl; 1991; 80():69-74. PubMed ID: 1666447
[TBL] [Abstract][Full Text] [Related]
5. [Antiviral drug therapy of infections caused by Herpes simplex and Varicella Zoster viruses].
Vogt M; Huss R; Wunderli W
Schweiz Med Wochenschr; 1992 Apr; 122(16):569-75. PubMed ID: 1579862
[TBL] [Abstract][Full Text] [Related]
6. Antiviral therapy for varicella and herpes zoster.
Arvin AM
Semin Pediatr Infect Dis; 2002 Jan; 13(1):12-21. PubMed ID: 12118839
[TBL] [Abstract][Full Text] [Related]
7. Clinical and subclinical reactivations of varicella-zoster virus in immunocompromised patients.
Ljungman P; Lönnqvist B; Gahrton G; Ringdén O; Sundqvist VA; Wahren B
J Infect Dis; 1986 May; 153(5):840-7. PubMed ID: 3009635
[TBL] [Abstract][Full Text] [Related]
8. Utility of ultra-deep sequencing for detection of varicella-zoster virus antiviral resistance mutations.
Mercier-Darty M; Boutolleau D; Lepeule R; Rodriguez C; Burrel S
Antiviral Res; 2018 Mar; 151():20-23. PubMed ID: 29337163
[TBL] [Abstract][Full Text] [Related]
9. Acyclovir therapy of varicella-zoster virus infections in immunocompromised patients.
Balfour HH; McMonigal KA; Bean B
J Antimicrob Chemother; 1983 Sep; 12 Suppl B():169-79. PubMed ID: 6313596
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic approaches to varicella-zoster virus infections.
Whitley RJ
J Infect Dis; 1992 Aug; 166 Suppl 1():S51-7. PubMed ID: 1378081
[TBL] [Abstract][Full Text] [Related]
11. Varicella zoster virus infections following allogeneic bone marrow transplantation: frequency, risk factors, and clinical outcome.
Koc Y; Miller KB; Schenkein DP; Griffith J; Akhtar M; DesJardin J; Snydman DR
Biol Blood Marrow Transplant; 2000; 6(1):44-9. PubMed ID: 10707998
[TBL] [Abstract][Full Text] [Related]
12. Comparison of acyclovir and vidarabine in immunocompromised children with varicella-zoster virus infection.
Kunitomi T; Akazai A; Ikeda M; Oda M; Kodani N
Acta Paediatr Jpn; 1989 Dec; 31(6):702-5. PubMed ID: 2516397
[TBL] [Abstract][Full Text] [Related]
13. Varicella-zoster infection after allogeneic bone marrow transplantation: incidence, risk factors and prevention with low-dose aciclovir and ganciclovir.
Steer CB; Szer J; Sasadeusz J; Matthews JP; Beresford JA; Grigg A
Bone Marrow Transplant; 2000 Mar; 25(6):657-64. PubMed ID: 10734301
[TBL] [Abstract][Full Text] [Related]
14. Varicella-zoster virus infections in immunocompromised patients - a single centre 6-years analysis.
Wiegering V; Schick J; Beer M; Weissbrich B; Gattenlöhner S; Girschick HJ; Liese J; Schlegel PG; Eyrich M
BMC Pediatr; 2011 May; 11():31. PubMed ID: 21569228
[TBL] [Abstract][Full Text] [Related]
15. Varicella zoster infection after bone marrow transplantation: incidence, risk factors and complications.
Han CS; Miller W; Haake R; Weisdorf D
Bone Marrow Transplant; 1994 Mar; 13(3):277-83. PubMed ID: 8199570
[TBL] [Abstract][Full Text] [Related]
16. Management of varicella-zoster virus infections in children.
Arvin AM
Adv Exp Med Biol; 1999; 458():167-74. PubMed ID: 10549389
[TBL] [Abstract][Full Text] [Related]
17. Clinical course and therapeutic approach to varicella zoster virus infection in children with rheumatic autoimmune diseases under immunosuppression.
Leuvenink R; Aeschlimann F; Baer W; Berthet G; Cannizzaro E; Hofer M; Kaiser D; Schroeder S; Heininger U; Woerner A
Pediatr Rheumatol Online J; 2016 Jun; 14(1):34. PubMed ID: 27256096
[TBL] [Abstract][Full Text] [Related]
18. [Intravenous acyclovir (ACV, Zovirax) therapy of varicella zoster infections in immunologically endangered patients].
Kerpel-Fronius S; Nyerges G; Mészner Z; Eckhardt S; Walker E; Bridgen D
Orv Hetil; 1983 Nov; 124(48):2913-8. PubMed ID: 6657237
[No Abstract] [Full Text] [Related]
19. Factors influencing varicella zoster virus infection after allogeneic peripheral blood stem cell transplantation: low-dose acyclovir prophylaxis and pre-transplant diagnosis of lymphoproliferative disorders.
Kim DH; Messner H; Minden M; Gupta V; Kuruvilla J; Wright J; Lipton J
Transpl Infect Dis; 2008 Apr; 10(2):90-8. PubMed ID: 17605742
[TBL] [Abstract][Full Text] [Related]
20. Comparative trial of acyclovir and vidarabine in disseminated varicella-zoster virus infections in immunocompromised patients.
Vildé JL; Bricaire F; Leport C; Renaudie M; Brun-Vézinet F
J Med Virol; 1986 Oct; 20(2):127-34. PubMed ID: 3534140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
